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Editorial

Importance of implementation economics for program planning—
evaluation of CDC’s colorectal cancer control program

Understanding the cost of initiating and operationalizing
colorectal cancer (CRC) control programs is essential for planning
successful implementation of evidence-based recommendations
to reduce disparities in the use and quality of CRC cancer screening
services. Currently, only about 58% of adults ages 50–75 years in
the United States are up-to-date with CRC screening recommendations; adults without health insurance have a much lower
uptake of about 24% (Sabatino, White, Thompson, & Klabunde,
2015). Targeted interventions and programs, especially those
focused on the uninsured and underinsured populations, are
required to meet the population-wide target of 80% by 2018 set by
The National Colorectal Cancer Roundtable (NCCRT, n.d.). The
Community Guide contains several evidence-based recommendations for screening promotion interventions but there are very few
studies on the economics of screening program implementation
(Baron et al., 2010; Sabatino et al., 2012). There is an urgent need to
increase the number of ‘implementation economics’ studies to
develop the evidence-base to guide funding decision making,
design cost-effective programs and ensure optimal use of limited
resources. We deﬁne ‘implementation economics’ as a subdiscipline within implementation science that focusses on
economic evaluation related to cost (cost-of-illness analysis,
program cost analysis), cost-effectiveness, cost-beneﬁt, costutility, budget impact, and cost minimization.
For more than a decade, CDC has funded and provided technical
support to a range of grantee programs to implement CRC
screening and implementation economics has been a cornerstone
of the evaluations of these programs. Between 2005 and 2009, CDC
administered the Colorectal Cancer Screening Demonstration
Program (CRCSDP) in ﬁve programs [Baltimore, Maryland; St.
Louis, Missouri; the entire state of Nebraska; Suffolk County, New
York; and King, Clallam and Jefferson counties in Washington]
(Centers for Disease Control and Prevention, 2013a). These
programs provided colorectal cancer screening for low-income,
underinsured, or uninsured men and women between the ages of
50 and 64 years. In 2009, successes and lessons learned (Centers
for Disease Control and Prevention, 2013b; Joseph, DeGroff, Hayes,
Wong, & Plescia, 2011) from the CRCSDP informed planning and
funding of the ﬁrst round of CDC’s Colorectal Cancer Control
Program (CRCCP) (2009–2015). Through the CRCCP, CDC provided
funding to 22 states and 4 tribal organizations to implement CRC
programs starting in 2009 and another 3 states were added to the
program in 2010. Fig. 1 provides a map of the United States
highlighting the CRCCP grantees.
http://dx.doi.org/10.1016/j.evalprogplan.2016.11.007
0149-7189/Published by Elsevier Ltd.

The CRCCP represents a new approach for disseminating
evidence-based interventions and promoting their use while
simultaneously ensuring free screening for a portion of the
medically underserved population. The CRCCP grantees used
about two thirds of their funds to implement the population
based promotion activities (screening promotion) and the
remaining third to deliver direct clinical screening services for
low income uninsured individuals (screening provision). The
grantees were encouraged to tailor the program to their individual
settings within the broad framework provided by the CDC. To
implement screening provision the grantees partnered with
numerous organizations including Federally Qualiﬁed Health
Centers, other health care systems, State Medicaid ofﬁces,
professional organizations, employers and worksites, and private
insurers. For screening provision, all grantees used United States
Preventive Task Force recommended tests with some using
colonoscopies, others using fecal based tests and several program
providing multiple screening tests.
Several peer-reviewed manuscripts based on the economic
evaluation of the earlier CRCSDP have been published (Subramanian, Bobashev, & Morris, 2010; Subramanian et al., 2013; Tangka
et al., 2008; Tangka et al., 2013). These studies contributed to the
implementation economics literature by quantifying the cost of
starting and implementing CRC screening programs, assessing the
resources required for speciﬁc programmatic activities and
evaluating the clinical cost of delivering screening services. In
this volume of Evaluation and Program Planning (Hoover et al.,
under review; Subramanian et al., under review; Tangka et al.,
under review) we present a collection of three new studies on
implementation economics that provide additional evidence to
guide future colorectal cancer screening programs. These manuscripts provide a comprehensive evaluation as they represent the
program, clinical and patient perspectives. Each of these different
perspectives offers a unique opportunity to understand the
viewpoint of key stakeholders involved in operationalizing
screening programs and in combination offer a unique opportunity
to assess multi-level factors required to ensure the success of these
programs. For instance, understanding patient motivation, facilitators and barriers is critical to ensure individuals initiate
screening and remain compliant with recommended screening
schedules.
In the ﬁrst manuscript, Tangka et al. (under review) focus on the
program perspective and provide a detailed review of the
screening promotion interventions implemented by the CRCCP
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Fig. 1. CDC’s Colorectal Cancer Control Program Grantees (1999–2015).

grantees along with the funding appropriated to each type of
intervention. A key goal of the CRCCP was to encourage programs
to adopt evidence-based interventions to promote screening with
the aim of increasing colorectal screening at the population level.
The results showed that all grantees engaged in at least one of The
Community Guide-recommended strategies, including patient
reminders and provider assessment, and the majority of the funds
were expended on the strategies supported by the available
evidence base. Approximately one-third of funding was spent on
mass media which is not currently recommended due to lack of
evidence; this ﬁndings was instrumental in shaping CDC’s policies
that changed from broad based recommendations to targeted
speciﬁc guidance and education on evidence-based interventions
(Centers for Disease Control and Prevention, 2015). This study did
not directly assess increases in population screening use, but
suggested that a 5% increase in CRC screening could have been
achieved for less than $35 per person.
In the second manuscript, Subramanian et al. (under review)
address the clinical perspective by comparing the non-clinical
(programmatic) and clinical cost of screening programs that use
Fecal Occult Blood Test (FOBT) or Fecal Immunochemical Test (FIT)
versus colonoscopy. Non-clinical costs include all costs not directly
related to provision of clinical services such as cost for patient
navigation, program management, quality assurance and professional development, partnership development and maintenance,
data collection and tracking, and program monitoring and
evaluation. Over the 3-year study period, colonoscopy programs
had higher clinical costs per person screened than FOBT/FIT.
Overall, FOBT/FIT-based and colonoscopy programs had similar
non-clinical costs per person served of approximately $1000. The
authors conclude that CRC screening programs incur substantial

non-clinical costs, regardless of whether the program is colonoscopy or FOBT/FIT-based and therefore both non-clinical and
clinical costs could be considered in future program planning
and funding decision making.
The last manuscript in this series focuses on the patient
perspective and reports on ﬁndings from a patient survey. Hoover
et al. (under review) reveal that even when colonoscopies were
provided free, patients incurred signiﬁcant costs related to lost
productivity and travel. Among the low income population of
mostly uninsured individuals in Philadelphia, patients incurred an
average cost of about $340 and caregivers who accompanied the
patients to visits incurred approximately $80. These patient and
caregiver costs may be important barriers that contribute to low
CRC screening use, especially among the low-income population.
The lessons learned from these three papers offer valuable
insight to the broad range of stakeholders actively engaged in CRC
control initiatives. First, through the use of systematic data
collection processes, detailed cost and resource use information
can be successfully collected from CRC programs, providers, and
clients. The data collection tools and surveys developed through
the CRCCP evaluation provide standardized instruments for future
research. Second, to successfully implement CRC screening
promotion and provision activities, programs have to engage in
multiple activities related to programmatic oversight and clinical
services. Therefore, adequate funding need to be provided so these
interlinked activities can be established and operationalized. Third,
it is important to assess costs from multiple perspectives,
especially those incurred by patients which are often not included
in economic evaluation of cancer screening. Costs borne by
patients related to lost wages and transportation can be important
barriers that need to be further evaluated.
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Additionally lessons learned from these CRC program economic
evaluations were incorporated in planning the second round of
CRCCP funding (New CRCCP) (2015–2020) through which CDC
funded 24 state health departments, 6 universities, and one
American Indian tribe (Centers for Disease Control and Prevention,
2015). CDC is continuing its commitment to advance the science of
implementation economics by supporting a systematic evaluation
of selected current CRCCP grantees. Evaluation of the costeffectiveness of effective interventions can identify the most
efﬁcient use of available resources, contribute to the economics
evidence-base for the Community Guide, and help increase
colorectal cancer screening rates to meet national goals (NCCRT,
n.d.). These future economic studies will continue to build on the
evidence base initiated through the publications of the compilation of the three papers presented in this volume of Evaluation and
Program Planning.
Finally, the lessons learned through these studies can be
generalized beyond the CRCCP and colorectal cancer screening to
other non-communicable disease management programs. Patient
compliance and cost-effective delivery of multi-component
programs remains a challenge across a wide range of screening
and treatment modalities including cervical and breast cancer
screening, and hypertension and diabetes management. Performing economic evaluation incorporating a wide variety of perspectives can provide a more comprehensive understanding of
facilitators and barriers to help design programs that are both
efﬁcient and effective in achieving their goals.
Funding
This work was funded in part by Centers for Disease Control and
Prevention Contract Number 200–2008-27958, Task Order 01, to
RTI International.
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